New drug offers hope to patients with life-threatening heart condition – study
People diagnosed with a life-threatening heart condition have been given fresh hope thanks to a ground-breaking new drug, researchers say.
A study shows that patients with transthryretin amyloid cardiomyopathy, (ATTR-CM), now the most commonly diagnosed form of amyloidosis (protein build up in the body), benefited significantly when they took the drug Acoramidis.
Left untreated, clumps of protein build up on the heart preventing
